Komodo Health and ZERO Prostate Cancer Announce Partnership

The collaboration aims to improve prostate cancer screening and early detection.

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Komodo Health, a leading healthcare analytics company, and ZERO - The End of Prostate Cancer, a national non-profit organization, have announced a new partnership to help close gaps in prostate cancer screening and early detection. The collaboration will leverage Komodo's data-driven insights and ZERO's patient education and outreach programs to identify underserved populations and connect them with necessary screening and preventive services.

Why it matters

Prostate cancer is the second most common cancer among men in the United States, yet screening rates remain low, especially among certain demographic groups. This partnership aims to address disparities in prostate cancer care and improve health outcomes for men at risk.

The details

Through the partnership, Komodo Health will provide data and analytics to help ZERO target its outreach and education efforts towards high-risk populations. ZERO will then connect these individuals with local screening providers and support services to encourage early detection and treatment. The organizations believe this data-driven, community-based approach can have a meaningful impact on prostate cancer outcomes.

  • The partnership was announced on March 4, 2026.

The players

Komodo Health

A leading healthcare analytics company that leverages real-world data to generate insights and drive improved health outcomes.

ZERO - The End of Prostate Cancer

A national non-profit organization dedicated to ending prostate cancer through research, education, and patient support programs.

Got photos? Submit your photos here. ›

What they’re saying

“We're excited to partner with ZERO to help address the critical issue of prostate cancer screening and early detection. By combining our data-driven insights with ZERO's community-based approach, we can make a real difference in the lives of men at risk.”

— Arif Nathoo, CEO, Komodo Health (Business Wire)

“This partnership with Komodo Health will allow us to more effectively reach and support the men who need prostate cancer screening the most. Together, we can work to ensure no man faces prostate cancer alone.”

— Jamie Bearse, President and CEO, ZERO - The End of Prostate Cancer (Business Wire)

What’s next

The partnership is expected to launch new patient outreach and screening initiatives in the coming months.

The takeaway

By combining data-driven insights and community-based programs, this partnership between Komodo Health and ZERO aims to improve prostate cancer screening and early detection, ultimately saving lives and reducing disparities in prostate cancer care.